Cytomx Therapeutics Inc (CTMX)

Jan 29, 2025

Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago - Yahoo Finance

Jan 29, 2025

Jan 25, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 25, 2025

Jan 25, 2025

Assenagon Asset Management S.A. Sells 1,044,318 Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jan 25, 2025

Jan 23, 2025

Keros Therapeutics Stock Plunges 81% in 3 Months: Here's Why - Yahoo Finance

Jan 23, 2025

Jan 20, 2025

Short Interest in CytomX Therapeutics, Inc. (NASDAQ:CTMX) Drops By 13.4% - MarketBeat

Jan 20, 2025

Jan 17, 2025

Jane Street Group LLC Decreases Stock Holdings in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jan 17, 2025

Jan 17, 2025

Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Price Target at $5.77 - Defense World

Jan 17, 2025

Jan 15, 2025

Bay Area biotech firm CytomX, once worth $2.3 billion, lays off 40% of staff - MSN

Jan 15, 2025

Jan 14, 2025

CytomX stock plunges to 52-week low, touches $0.83 By Investing.com - Investing.com Canada

Jan 14, 2025

Jan 14, 2025

CytomX stock plunges to 52-week low, touches $0.83 - Investing.com India

Jan 14, 2025

Jan 14, 2025

Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Target Price at $5.77 - MarketBeat

Jan 14, 2025

Jan 13, 2025

Bay Area biotech firm once worth $2.3 billion lays off 40% of staff - SFGATE

Jan 13, 2025

Jan 11, 2025

Geode Capital Management LLC Has $948,000 Stock Position in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jan 11, 2025

Jan 10, 2025

CytomX Therapeutics’ (CTMX) Neutral Rating Reiterated at HC Wainwright - Defense World

Jan 10, 2025

Jan 08, 2025

Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights

Jan 08, 2025

Jan 08, 2025

HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal - Nasdaq

Jan 08, 2025

Jan 08, 2025

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025

Jan 08, 2025

CytomX Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 08, 2025

Jan 07, 2025

CytomX falls after portfolio shakeup, job cuts - MSN

Jan 07, 2025

Jan 07, 2025

CytomX Therapeutics' SWOT analysis: oncology biotech's stock faces pivotal year - Investing.com

Jan 07, 2025

Jan 07, 2025

CytomX stock falls on portfolio shakeup (CTMX:NASDAQ) - Seeking Alpha

Jan 07, 2025

Jan 07, 2025

All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy - Yahoo Finance

Jan 07, 2025

Jan 07, 2025

CytomX to Cut 40% of Staff as It Updates Pipeline Priorities - BioSpace

Jan 07, 2025

Jan 07, 2025

CytomX Therapeutics (NASDAQ:CTMX) Receives "Neutral" Rating from HC Wainwright - MarketBeat

Jan 07, 2025

Jan 06, 2025

CytomX refocuses on key cancer drug, extends cash runway - Investing.com India

Jan 06, 2025

Jan 06, 2025

CTMXCytomX Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Jan 06, 2025

Jan 06, 2025

CytomX announces restructuring, staff cuts to extend cash runway - Investing.com

Jan 06, 2025

Jan 06, 2025

CytomX announces restructuring, staff cuts to extend cash runway By Investing.com - Investing.com South Africa

Jan 06, 2025

Jan 06, 2025

CytomX refocuses on key cancer drug, extends cash runway By Investing.com - Investing.com Canada

Jan 06, 2025

Jan 06, 2025

Peninsula biotech to lay off 40% of workforce as it restructures - The Business Journals

Jan 06, 2025

Jan 06, 2025

CytomX Therapeutics to Cut 40% of Workforce - MarketWatch

Jan 06, 2025

Jan 06, 2025

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update - The Manila Times

Jan 06, 2025

Jan 03, 2025

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA - Zacks Investment Research

Jan 03, 2025

Dec 31, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Short Interest Up 26.2% in December - MarketBeat

Dec 31, 2024

Dec 23, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives $5.77 Average Price Target from Analysts - Defense World

Dec 23, 2024

Dec 21, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Position Raised by Fmr LLC - Defense World

Dec 21, 2024

Dec 20, 2024

Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine - MSN

Dec 20, 2024

Dec 20, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 20, 2024

Dec 18, 2024

CytomX Therapeutics (NASDAQ:CTMX) Stock Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat

Dec 18, 2024

Dec 18, 2024

SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS - MSN

Dec 18, 2024

Dec 17, 2024

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Shares Bounce 26% But Its Business Still Trails The Industry - Simply Wall St

Dec 17, 2024

Dec 16, 2024

CytomX Therapeutics (CTMX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Dec 16, 2024

Dec 13, 2024

CytomX Therapeutics' SWOT analysis: biotech stock's solid tumor focus By Investing.com - Investing.com Canada

Dec 13, 2024

Dec 10, 2024

Janus Henderson Group PLC Trims Stake in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - MarketBeat

Dec 10, 2024

Dec 06, 2024

Recent uptick might appease CytomX Therapeutics, Inc. (NASDAQ:CTMX) institutional owners after losing 21% over the past year - Simply Wall St

Dec 06, 2024

Nov 30, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Short Interest Down 21.7% in November - MarketBeat

Nov 30, 2024

Nov 28, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives $5.77 Consensus Price Target from Brokerages - Defense World

Nov 28, 2024

Nov 27, 2024

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - The Manila Times

Nov 27, 2024